Colorado Zantac expert witnesses assess ranitidine use and alleged cancer risks within Colorado’s clinical and regulatory landscape. They often come from oncology, gastroenterology, clinical pharmacology, toxicology, and epidemiology, with experience in Front Range academic medical centers and statewide hospital networks. They commonly evaluate NDMA exposure, prescribing standards, causation, and patient outcomes.